We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Smartphone System Detects Irregular Heartbeats

By HospiMedica International staff writers
Posted on 29 Sep 2016
Print article
Image: The Beat2Phone device measures ECG signals and sends them to a cellphone (Photo courtesy of VTT).
Image: The Beat2Phone device measures ECG signals and sends them to a cellphone (Photo courtesy of VTT).
A mobile app and thumb-sized device help to prevent cerebral infarctions by detecting early-onset atrial fibrillation (AF).

Developed by researchers at the Technical Research Centre of Finland (VTT; Espoo), the Beat2Phone device measures electrocardiogram (ECG) signals at a very high sampling rate, identify individual heartbeats and counting the interval between consecutive beats. By accurately measuring the user's heart rate and heart rate variability, the device can detect not only an irregular heartbeat, but also overburdening and prolonged stress, as evidenced by a high resting heart rate and low heart rate variability.

The mobile device has been tested so far by about 30 heart patients at Turku University Hospital (Finland), some of whom have also worn the device at night. The test population includes people who have reported heart symptoms that were not detected during Holter monitoring, as well as by athletes and professional sportspersons with heart conditions who need to monitor their heart activity regularly, as changes in ECG may be an indicator of myocarditis or other serious conditions.

In the tests, the device helped to detect AF, arrhythmia, and a cardiac conduction disorder, sending a notification directly to the user’s cell phone. Once the Beat2Phone ECGs were reviewed by a physician, the patients were admitted for further tests. According to the developers, other potential users of the device include monitoring people suffering from sleep apnea, as well those who suffer from musculoskeletal disorders such as neck, shoulder, and lower back pain, tennis elbow, and repetitive strain injury, which are common among office workers.

“With the mobile device developed by VTT, users can register their ECG signal whenever arrhythmia or other heart symptoms occur,” said Timo Varpula, PhD, principal scientist at VTT. “The device is also suitable for pre- and post-surgery monitoring of heart patients at home. There is no need for patients to visit a hospital, because the data is sent automatically from a mobile phone to medical staff via a cloud service.”

Related Links:
Technical Research Centre of Finland
Turku University Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Enterprise Imaging & Reporting Solution
Syngo Carbon

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more